Exploring HIV prevention preferences among gay and bisexual men.

Understanding HIV/STD Risk and Enhancing PrEP Implementation Messaging in a Diverse Community-Based Sample of Gay, Bisexual, and Other Men Who Have Sex with Men in a Transformational Era

NIH-funded research Emory University · NIH-10828875

This study is looking at how gay, bisexual, and other men who have sex with men choose and think about HIV prevention methods, especially a medication called PrEP, and it’s for those living in places like Atlanta, Detroit, and San Diego who want to share their experiences and help improve prevention strategies while keeping track of their health.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionEmory University NIH-funded
Lab location1 site (Atlanta, United States)
Project IDNIH-10828875 on NIH RePORTER

What this research studies

This research investigates how gay, bisexual, and other men who have sex with men (MSM) perceive and choose HIV prevention methods, particularly focusing on the use of pre-exposure prophylaxis (PrEP). Participants will be enrolled from diverse locations including Atlanta, Detroit, and San Diego, and will undergo regular assessments over two years to gather data on their preferences and behaviors. The study includes both quantitative assessments and qualitative discussions to refine messaging around PrEP and other prevention strategies. Additionally, participants will receive HIV and STI testing to monitor their health throughout the study.

Who could benefit from this research

Good fit: Ideal candidates for this research are gay, bisexual, and other men who have sex with men, particularly those living in or near the study locations.

Not a fit: Patients who do not identify as men who have sex with men or those outside the specified geographic areas may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could enhance the effectiveness of HIV prevention strategies and improve health outcomes for MSM.

How similar studies have performed: Previous research has shown success in understanding HIV prevention preferences among MSM, making this approach both relevant and potentially impactful.

Where this research is happening

Atlanta, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.